A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: The NEU screen

Jose A. Muñoz-Moreno, Anna Prats, Núria Pérez-Álvarez, Carmina R. Fumaz, Maite Garolera, Eduardo Doval, Eugènia Negredo, Maria J. Ferrer, Bonaventura Clotet

Research output: Contribution to journalArticleResearchpeer-review

22 Citations (Scopus)

Abstract

Objective: Practical screening methods are necessary to detect neurocognitive impairment (NCI) in HIV-infected patients. We aimed to find a brief and feasible paper-based tool to facilitate the diagnosis of an HIV-associated neurocognitive disorder. Methods: A total of 106 HIV-infected outpatients with variable clinical characteristics were recruited in a multicenter investigation. NCI was diagnosed using a standardized neuropsychological tests battery (7 areas, 21 measures, ∼2 hours). Multiple score combinations were compared to find a paper-based method that took ≤10 minutes to apply. The presence of NCI was considered the gold standard for comparisons, and the sensitivity and specificity were calculated. Results: Subjects were mostly middle-aged (median, 44 years) men (87%) on antiretroviral treatment. NCI was detected in 51 individuals (48%) and was associated with lower nadir CD4 count (P < 0.001), receiving antiretroviral therapy (P = 0.004), fewer years of education (P = 0.009), and presence of comorbidities (P < 0.001). The score combination that showed the highest sensitivity (74.5%) and specificity (81.8%) detecting NCI included 3 measures of attention/ working memory, executive functioning, and verbal fluency (part A of Trail Making Test, part B of Trail Making Test, and Controlled Oral Word Association Test scores). A broader paperbased selection of measures covering 7 areas indicated a sensitivity of 100% and a specificity of 96.3% (7 measures, ∼35 minutes). Conclusions: The combination of the 3 measures presented in this study seems to be a rapid and feasible screening mean for NCI in HIVinfected patients. This approach, combined with screening for potential comorbidities and daily functioning interference, could help in the initial stages of a HIV-associated neurocognitive disorder diagnosis and in settings with limited access to neuropsychological resources. Copyright © 2013 by Lippincott Williams & Wilkins.
Original languageEnglish
Pages (from-to)585-592
JournalJournal of acquired immune deficiency syndromes (1999)
Volume63
Issue number5
DOIs
Publication statusPublished - 15 Aug 2013

Keywords

  • HIV infection
  • Neurocognitive impairment
  • Screening methods

Fingerprint

Dive into the research topics of 'A brief and feasible paper-based method to screen for neurocognitive impairment in HIV-infected patients: The NEU screen'. Together they form a unique fingerprint.

Cite this